Drug recall · June 28, 2017
Venlafaxine Hydrochloride Extended-Release Capsules USP recall
Why: Failed Tablet/Capsules Specifications: pharmacists complaints for bottles containing melted capsules.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Venlafaxine Hydrochloride Extended-Release Capsules USP, 75 mg, packaged in a) 30-count bottles (NDC 52343-132-30) and b) 90-count bottles (NDC 52343-132-90), Rx only, Distributed by: Lucid Pharma LLC, 2 Tower Center Blvd, Suite-1101-B, East Brunswick, NJ 08816 USA.
- Lots / codes
Lot #: a) V17516045-A, Exp 08/18; b) V17516047-A 09/18
- Quantity
- a) 44168 bottles; b) 24960 bottles
- Company
- Lucid Pharma LLC, East Brunswick, NJ
- Distribution
- Nationwide in the USA
- Initiated
- June 1, 2017 · Voluntary: Firm initiated
- Classified
- June 16, 2017
- Reported
- June 28, 2017
- Ended
- September 25, 2019
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Venlafaxine
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.